Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Community pharmacist-led medication review procedures across Europe: Characterization, implementation and remuneration
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4526635
Author(s) Imfeld-Isenegger, Tamara Leila; Soares, InÍs Branco; Makovec, Urska Nabergoj; Horvat, Nejc; Kos, Mitja; van Mil, Foppe; Costa, Filipa A.; Hersberger, Kurt E.
Author(s) at UniBasel Imfeld-Isenegger, Tamara
Hersberger, Kurt
Year 2020
Title Community pharmacist-led medication review procedures across Europe: Characterization, implementation and remuneration
Journal Research in Social and Administrative Pharmacy
Volume 16
Number 8
Pages / Article-Number 1057-1066
Keywords Community pharmacy services; Europe; Medication review; Primary health care; Remuneration; Service implementation
Abstract Pharmaceutical Care Network Europe (PCNE) proposed a definition and classification system (type 1, 2a, 2b, 3) for medication review in 2016. However, to date, a description of the implementation and remuneration of such procedures across Europe is lacking.; The aim of this study was to describe the medication review procedures and the level of implementation and remuneration in community pharmacies across Europe.; An online survey was developed to characterize medication review procedures (PCNE classification), level of implementation (considering regional or national) and remuneration by a third party. This survey was sent to a purposive sample of three individuals per country, with a working background in community pharmacy, pharmacy practice research, or health policy to ensure reliable data. Data triangulation was used and consensus sought between the responses.; Data were received from 34 out of 44 targeted European countries (November 2016-October 2017) [response rate†=†77%]. Overall, 55.9% of the countries provided at least one type of medication review as an implemented service or project. Type 1 medication review (based on the medication history) was provided in 13 countries, type 2a (medication history†+†patient interview) in 14, type 2b (medication history†+†clinical data) in two, and type 3 medication review (medication history†+†patient interview†+†clinical data) in four countries. Ten of the mentioned services or projects were remunerated by a third-party.; Substantial heterogeneity was observed across Europe in various aspects, including the procedures, implementation level and remuneration obtained. Type 1 and 2a medication review services seem to be more feasible to implement in the community pharmacy than type 2b and 3. A large number of medication review projects were ongoing in community pharmacies, which suggests that new medication review services could become implemented in the coming years.
Publisher Elsevier
ISSN/ISBN 1551-7411 ; 1934-8150
edoc-URL https://edoc.unibas.ch/74584/
Full Text on edoc No
Digital Object Identifier DOI 10.1016/j.sapharm.2019.11.002
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/31734100
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.316 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
19/04/2024